Non-small-cell lung cancer in a French department, (1982–1997): management and outcome
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602342.pdf
Reference47 articles.
1. Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1991) Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group Experience. J Clin Oncol 9: 1618–1626
2. Bolliger CT, Perruchoud AP (1998) Functional evaluation of the lung resection candidate. Eur Respir J 11: 198–212
3. Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O'Connell M, Shepherd FA, Johnson BE (2001) Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol 19: 1734–1742
4. Cartman ML, Hatfield AC, Muers MF, Peake MD, Haward RA, Forman D (2002) Lung cancer: district active treatment rates affect survival. J Epidemiol Commun Health 56: 424–429
5. Charloux A, Hedelin G, Dietemann A, Ifoundza T, Roeslin N, Pauli G, Quoix E (1997) Prognostic value of histology in patients with non-small cell lung cancer. Lung Cancer 17: 123–134
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-small-Cell Lung Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2022
2. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-Small-Cell Lung Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2021-10-14
3. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-Small-Cell Lung Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2021
4. A simple method for correcting for the Will Rogers phenomenon with biometrical applications;Biometrical Journal;2020-01-20
5. Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial;The Oncologist;2019-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3